RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Effect of the suspension of the J&J COVID-19 vaccine on vaccine hesitancy in the United States
Hsieh, Y. L., Rak, S., SteelFisher, G. K., & Bauhoff, S. (2022). Effect of the suspension of the J&J COVID-19 vaccine on vaccine hesitancy in the United States. Vaccine, 40(3), 424-427. https://doi.org/10.1016/j.vaccine.2021.11.085
On April 13, 2021, U.S. authorities announced an investigation into potential adverse events associated with the Johnson & Johnson (Janssen, J&J) COVID-19 vaccine and recommended "a pause in the use of this vaccine out of an abundance of caution." We examined whether public attitudes toward COVID-19 vaccination shifted after this recommended suspension using an interrupted time series with data from the Census Bureau's Household Pulse Survey, which was fielded bi-weekly between January 6 and April 26, 2021. We found no significant changes in trends of the proportion of the U.S. adult population hesitant about getting a COVID-19 vaccine, but a significant increase in concerns about safety and efficacy of COVID-19 vaccines among the already hesitant population. (C) 2021 Elsevier Ltd. All rights reserved.